trending Market Intelligence /marketintelligence/en/news-insights/trending/oic0ztwjjkqo_tcg5gaoia2 content esgSubNav
In This List

Eagle Pharmaceuticals chief scientific officer to step down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Eagle Pharmaceuticals chief scientific officer to step down

Eagle Pharmaceuticals Inc. said Steven Krill, executive vice president and chief scientific officer, will leave the company Feb. 26.

Krill has been chief scientific officer since February 2013.

Woodcliff Lake, N.J.-based Eagle Pharmaceuticals develops injectable products primarily in the critical care and oncology areas.